These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 15521018)

  • 1. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.
    Fiorucci S; Antonelli E; Rizzo G; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pellicciari R; Morelli A
    Gastroenterology; 2004 Nov; 127(5):1497-512. PubMed ID: 15521018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis.
    Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Morelli A; Pruzanski M; Pellicciari R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):58-68. PubMed ID: 15980055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis.
    Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pruzanski M; Morelli A; Pellicciari R
    J Pharmacol Exp Ther; 2005 Aug; 314(2):584-95. PubMed ID: 15860571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
    Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A
    J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
    Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
    Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
    Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts.
    Renga B; Mencarelli A; Migliorati M; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
    Inflamm Res; 2011 Jun; 60(6):577-87. PubMed ID: 21279417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids.
    Chen W; Owsley E; Yang Y; Stroup D; Chiang JY
    J Lipid Res; 2001 Sep; 42(9):1402-12. PubMed ID: 11518759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner.
    Bae EH; Choi HS; Joo SY; Kim IJ; Kim CS; Choi JS; Ma SK; Lee J; Kim SW
    PLoS One; 2014; 9(1):e86553. PubMed ID: 24475141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone.
    Wang S; Lai K; Moy FJ; Bhat A; Hartman HB; Evans MJ
    Endocrinology; 2006 Sep; 147(9):4025-33. PubMed ID: 16675527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
    Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
    Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
    Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of FXR in regulating bile acid homeostasis and relevance for human diseases.
    Rizzo G; Renga B; Mencarelli A; Pellicciari R; Fiorucci S
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):289-303. PubMed ID: 16178789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity.
    Mencarelli A; Cipriani S; Renga B; D'Amore C; Palladino G; Distrutti E; Baldelli F; Fiorucci S
    Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):94-101. PubMed ID: 21924881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
    Ueki M; Koda M; Yamamoto S; Matsunaga Y; Murawaki Y
    J Gastroenterol; 2006 Oct; 41(10):996-1004. PubMed ID: 17096069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner.
    Kanaya E; Shiraki T; Jingami H
    Biochem J; 2004 Sep; 382(Pt 3):913-21. PubMed ID: 15202934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.